These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13415052)

  • 21. Antiviral activity of several quinone and isoquinoline derivatives.
    KUROYA M; ISHIDA N; KONNO J; SHIRATORI T; MIURA M; YOSHINARI Y
    J Antibiot (Tokyo); 1953 Apr; 6(2):90-1. PubMed ID: 13084507
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiviral activity of several quinone and isoquinoline derivatives.
    KUROYA M; ISHIDA N; KONNO J; SHIRATORI T; MIURA M; YOSHINARI Y
    Yokohama Med Bull; 1953 Apr; 4(2):73-7. PubMed ID: 13103148
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticancer potential of N,N-diethylaminoethyl ethers of flavanone oximes: a comparison with mitoxantrone action on rat Yoshida sarcoma cells in vivo.
    Metodiewa D; Kochman A; Koceva-Chyła A
    Anticancer Res; 1999; 19(2A):1249-54. PubMed ID: 10368684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polarographic analysis of cytostatic quinone derivatives. II. The redox system 2,5-bis-(ethyleneimine)-3,6-bis-(n-porpoxy)-benzoquinone-(1,4)].
    BERG H; KONIG KH
    Z Krebsforsch; 1958; 62(5):495-500. PubMed ID: 13625829
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. XV. Determination of minimum effective dose of nitromin and other compounds by in vitro tests.
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATOH H
    Gan; 1956 Dec; 47(3-4):382-4. PubMed ID: 13415048
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of compounds having unsaturated seven membered ring structure on Yoshida sarcoma. 3.
    AKAISHI K; CHIBA K; SATO K
    Gan; 1954 Sep; 45(2-3):507-10. PubMed ID: 13220965
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of lymphocyte transformation and microtubule assembly by quinone metabolites of benzene: evidence for a common mechanism.
    Irons RD; Neptun DA; Pfeifer RW
    J Reticuloendothel Soc; 1981 Nov; 30(5):359-72. PubMed ID: 7320996
    [No Abstract]   [Full Text] [Related]  

  • 28. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of compounds having unsaturated seven membered ring structure on Yoshida sarcoma. IV. Appendix: with two cases of clinical application of colchicine-derivatives].
    AKAISHI K; YOSHIMATSU S; AKAMA Y; SATO K
    Gan; 1955 Sep; 46(2-3):498-501. PubMed ID: 13262470
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antisecretory activity of some new compounds without anticholinergic activity].
    Rovati AL; Casula PL; Da Re G
    Minerva Med; 1967 Oct; 58(86):3651-3. PubMed ID: 6061057
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
    Colucci MA; Moody CJ; Couch GD
    Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in lysosomal enzyme activities of Yoshida sarcoma cells in rats treated with anticancer agents in relation to their therapeutic effects.
    Abe I; Sato S
    Sci Rep Res Inst Tohoku Univ Med; 1974 Dec; 21(3-4):76-86. PubMed ID: 4467316
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of quinone derivatives on insulin, glucagon, and insulinase. II. Influence of quonone derivatives on the blood sugar increasing action of glucagon].
    UEKI H; HAYASHI S
    Yakugaku Zasshi; 1962 May; 82():654-9. PubMed ID: 13923509
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibition of microsomal oxidation by o-benzoquinone derivatives].
    Kostiuk VA
    Biokhimiia; 1987 Mar; 52(3):355-8. PubMed ID: 3580408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacologic studies with trophosphamide (Ixoten), a new oxazaphosphorineoxide].
    Brock N
    Med Monatsschr; 1973 Sep; 27(9):390-4. PubMed ID: 4768197
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experiences with ethyleneimino-quinone (E 39) in chemotherapy of various neoplasms].
    DI PIETRO S
    Riforma Med; 1957 Jun; 71(22):608-14. PubMed ID: 13454502
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. XIII. Results of screening test.
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATOH H; IMAMURA H
    Gan; 1956 Dec; 47(3-4):375-9. PubMed ID: 13415046
    [No Abstract]   [Full Text] [Related]  

  • 38. Interrelations in respiratory, phosphorylative, and mitotic activity of Ehrlich ascites-tumor cells; influence of stilbestrol and quinone.
    SHACTER B
    J Natl Cancer Inst; 1956 Jun; 16(6):1453-8. PubMed ID: 13320123
    [No Abstract]   [Full Text] [Related]  

  • 39. [Failure of attempted treatment of multiregional lymphosarcomatosis with the new antitumoral quinone E 39].
    MOULINIER J
    J Med Bord; 1957 Jul; 134(7):953-6. PubMed ID: 13449493
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.
    Begleiter A; Leith MK; McClarty G; Beenken S; Goldenberg GJ; Wright JA
    Cancer Res; 1988 Apr; 48(7):1727-35. PubMed ID: 3127038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.